InvestorsHub Logo
Post# of 252254
Next 10
Followers 29
Posts 5148
Boards Moderated 0
Alias Born 05/24/2006

Re: genisi post# 150856

Sunday, 10/28/2012 11:14:04 AM

Sunday, October 28, 2012 11:14:04 AM

Post# of 252254
LLY

TUESDAY, OCTOBER 30TH Symposium 5 : Solanezumab Phase 3 results: Implications for Alzheimer's disease modification
Eric Siemers, MD, Eli Lilly, USA

http://www.ctad.fr/02-program/prog-2012/tuesday.asp#ancre11

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.